
EP Biocomposites Reports Strong Financial Performance in FY26, Highlights Growth Momentum
Goa, May 29, 2026: EP Biocomposites Limited, a manufacturer of fibre reinforced composite products and wastewater solutions, announced its audited financial results for the financial year ended March 31, 2026. The company reported significant growth across key financial metrics, reinforcing its expansion trajectory.The consolidated financial data for the second half of FY26 (H2FY26) shows robust growth compared to the previous years. The company recorded a 13.60% year-over-year increase in Revenue from Operations for FY26.
Financial performance metrics are detailed below:
| Particulars (Rs. In Lakh) | H2FY26 | H2FY25 | YoY% | FY25 |
|---|---|---|---|---|
| Revenue from Operations | 96339 | 76635 | 2571% | 120062 |
| Total Expenses | 781.73 | 655.72 | - | 118437 |
| EBITDA | 206.12 | 13495 | 52.74% | 188.41 |
| EBITDA (%) | 21.40% | 17.61% | - | 15.69% |
| PBT | 181.66 | 110.63 | 64.20% | 14170 |
| PAT | 136.79 | 8253 | 65.74% | 103.08 |
| PAT Margins (%) | 14.20% | 10.77% | - | 8.59% |
| Basic EPS (Rs.) | 8.13 | 4.91 | - | 6.13 |
The company reported a 26.23% increase in EBITDA over the last fiscal year and a 41.4% surge in PAT for FY26.
Key Operational and Financial Milestones
During FY26, EP Biocomposites Limited also achieved several key corporate milestones. Net worth crossed X12 crore as of March 31, 2026, reflecting continued financial strengthening. Furthermore, the company saw its Return on Assets (ROI) stand at 14%, while Return on Capital Employed (ROCE) improved to 16% during FY26. The company utilized proceeds from its Initial Public Offering (IPO) toward capacity expansion, working capital requirements, and other business growth initiatives. The focus on operational excellence and infrastructure enhancement was complemented by strengthening the balance sheet through partial debt repayment and improving the overall liquidity position.Management Commentary
Commenting on the strong results, Mr. Rajkumar Kamat, Managing Director of EP Biocomposites Limited, stated, "FY26 has been a significant year for EP Biocomposites Limited as we delivered healthy growth in revenue and profitability while continuing to strengthen our balance sheet and operational capabilities. Our focus on sustainable manufacturing solutions, efficient execution, and customer relationships has enabled us to achieve consistent performance. We remain optimistic about future growth opportunities and are committed to creating long-term value for all stakeholders."Company Overview
EP Biocomposites Limited is a Goa-based public limited company engaged in the manufacture and supply of sustainable infrastructure and polymer-based products across India. The company's core product portfolio includes a range of Fibre Reinforced Polymer (FRP) products such as door shutters, frames, laminated doors, biodigester tanks, bio toilets, fire doors, garden benches, and allied FRP solutions for construction, industrial, and infrastructure applications.Beyond construction, EP Biocomposites also provides sanitation and wastewater solutions. These include bio-digester toilets, Sewage Treatment Plants (STP), and Effluent Treatment Plants (ETP), which support efficient waste management and water reuse strategies for residential, commercial, institutional, and government projects. Driven by quality and environmental responsibility, the company designs products that are durable, low maintenance, and reduce environmental impact.
Stock Price Movement
EP Biocomposites Ltd shares settled at ₹108.70 on Wednesday, climbing substantially by 11.32% for the session. The stock tested a broad intraday range, moving between a low of ₹100.05 and a high of ₹112.95.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.